Comparison Chart Zydus Lifesciences Limited

Equities

Market Closed - NSE India S.E. Other stock markets 07:43:50 2024-05-10 EDT			5-day change	1st Jan Change
982.2 ^INR	+1.44%		-1.53%	+42.51%

05-10	India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says	RE
05-09	Zydus Lifesciences Limited Announces Completion of Enrolment for EPICS IIITM Phase 2B/3 Trial Evaluating Saroglitazar Mg in Treatment of Primary Biliary Cholangitis	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	ZYDUS LIFESCIENCES LIMITED	Generic Pharmaceuticals	+1.44%	-1.53%	+42.51%	+86.86%	+239.55%	11.83B